🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has removed violative material and banned associated keywords and query recommendations. The organization stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Research also discovered communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at home.

Within minutes of joining one group, a seller shared contact information, where the majority of transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts display black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals injured by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to potentially significant health risks”.